Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move. Takeda will no longer invest in ...
Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...
A former prisoner at the Burlington County Jail has filed a federal lawsuit against the facility and county officials, claiming he was ordered to strip and was severely beaten after he flooded his ...
Named after the 19th-century scientist who first described abnormal masses in the lymph nodes, Hodgkin lymphoma is a cancer of the lymphatic system. Around 10% of lymphoma diagnoses are categorized as ...
State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China University of Chinese Academy of Sciences, Beijing 100049, China ...
Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump attends the Ryder Cup golf ...
After Rep. Melissa Hortman’s assassination, her mentee takes up the mantle as House DFL leader Four-term DFL Rep. Zack Stephenson must now help negotiate legislation on gun-violence prevention with ...
DuoCAR20.19.22-D95 targets CD19, CD20, and CD22, addressing antigen escape in B-cell malignancies like B-ALL and B-NHL. Early-stage trials show no safety concerns for DuoCAR20.19.22-D95, with ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback